Experiences in the design and implementation of phase II trials in CLL

Similar Items

• Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL
  by: Munir, T, et al.
  Published: (2014)
• A comparison of oral and intravenous fludarabine in the LRF CLL4 trial (on behalf of the UKNCRI CLL trials group)
  by: Hillmen, P, et al.
  Published: (2006)
• The lack of survival differences in randomised trials in CLL may be related to the effect of second line therapies. A report from the LRF CLL4 trial.
  by: Catovsky, D, et al.
  Published: (2006)
• GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial
  by: Jamie B. Oughton, et al.
  Published: (2017-07-01)
• Comparison of oral and intravenous fludarabine in the LRF CLL4 trial.
  by: Hillmen, P, et al.
  Published: (2005)